Verb Surgical, which started as a collaboration between Johnson & Johnson and Alphabet's Verily unit for cheaper, smaller, and smarter surgical robots, will be wholly owned by J&J.
Johnson & Johnson (NYSE:JNJ) recently said its medical device business paid an undisclosed amount to acquire French robot-assisted surgery company Orthotaxy. Founded in 2009, Orthotaxy’s proprietary technology is currently in early-stage development for total and partial knee replacements. J&J plans to expand Orthotaxy’s technology into other orthopedic surgeries as part of its bid to create a new…
Johnson & Johnson (NYSE:JNJ) executives yesterday said the company is “on track” with its Verb Surgical prototype robot-assisted surgery platform, with chairman & CEO Alex Gorsky labeling the healthcare giant’s approach with Alphabet‘s (NSDQ:GOOGL) Verily Life Sciences as “computerized surgery.” “We are quite excited about our computerized surgery program. Everything up to this point in time is on track.…
[<a href=”//storify.com/MedTechDaily/getting-started” target=”_blank”>View the story “Robotic surgery: Here’s everything you need to know” on Storify</a>]
